PRTA - PROTHENA CORP PUBLIC LTD CO

QQQ $ 468.75 $ 0.00 (0 %)

DIA $ 409.73 $ 1.01 (0.25 %)

SPY $ 554.79 $ 5.63 (1.03 %)

TLT $ 100.61 $ -0.08 (-0.08 %)

GLD $ 232.25 $ -0.37 (-0.16 %)

Previous Close

$ 20.93

Open

Bid

$ 20.90 x 100

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 18.69 - $ 56.04

Volume

185,697

Average Volume

Market Cap

1.13B

Beta (5Y Monthly)

$ 0.96

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-08-2024	03-31-2024	10-Q
3	02-22-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	02-28-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-08-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	02-25-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-11-2021	03-31-2021	10-Q
15	02-26-2021	12-31-2020	10-K
16	11-04-2020	09-30-2020	10-Q
17	08-06-2020	06-30-2020	10-Q
18	05-06-2020	03-31-2020	10-Q
19	03-03-2020	12-31-2019	10-K
20	11-05-2019	09-30-2019	10-Q
21	08-06-2019	06-30-2019	10-Q
22	05-07-2019	03-31-2019	10-Q
23	03-15-2019	12-31-2018	10-K
24	11-06-2018	09-30-2018	10-Q
25	08-07-2018	06-30-2018	10-Q
26	05-09-2018	03-31-2018	10-Q
27	02-26-2018	12-31-2017	10-K
28	11-07-2017	09-30-2017	10-Q
29	08-09-2017	06-30-2017	10-Q
30	05-09-2017	03-31-2017	10-Q
31	02-27-2017	12-31-2016	10-K
32	11-02-2016	09-30-2016	10-Q
33	08-02-2016	06-30-2016	10-Q
34	05-04-2016	03-31-2016	10-Q
35	02-25-2016	12-31-2015	10-K
36	11-02-2015	09-30-2015	10-Q
37	08-05-2015	06-30-2015	10-Q
38	05-06-2015	03-31-2015	10-Q
39	03-13-2015	12-31-2014	10-K
40	11-04-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Oppenheimer Maintains Outperform on Prothe...
08/14/2024 12:34:26

Oppenheimer analyst Jay Olson maintains Prothena Corp (NASDAQ:PRTA) with a Outperform and lowers the price target from $66 t...

Cantor Fitzgerald Reiterates Overweight on...
08/12/2024 13:01:19

Cantor Fitzgerald analyst Charles Duncan reiterates Prothena Corp (NASDAQ:PRTA) with a Overweight.

RBC Capital Maintains Sector Perform on Pr...
08/09/2024 19:37:23

RBC Capital analyst Brian Abrahams maintains Prothena Corp (NASDAQ:PRTA) with a Sector Perform and lowers the price target f...

Prothena Corp Q2 Collaboration Revenue $13...
08/08/2024 20:37:33

RBC Capital Reiterates Sector Perform on P...
06/26/2024 15:05:25

RBC Capital analyst Brian Abrahams reiterates Prothena Corp (NASDAQ:PRTA) with a Sector Perform and maintains $28 price target.

Prothena to Receive $80 Million from Brist...
05/28/2024 20:08:17

JMP Securities Maintains Market Outperform...
05/09/2024 18:41:21

JMP Securities analyst Jason Butler maintains Prothena Corp (NASDAQ:PRTA) with a Market Outperform and lowers the price targ...

HC Wainwright & Co. Maintains Buy on Proth...
05/09/2024 17:57:25

HC Wainwright & Co. analyst Andrew Fein maintains Prothena Corp (NASDAQ:PRTA) with a Buy and lowers the price target fro...

Prothena Corp Q1 2024 GAAP EPS $(1.34) Mis...
05/08/2024 20:22:35

Prothena Corp (NASDAQ:PRTA) reported quarterly losses of $(1.34) per share which missed the analyst consensus estimate of $(1.2...

Prothena Announces Review On Birtamimab Me...
04/15/2024 20:10:56

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational t...

Cantor Fitzgerald Reiterates Overweight on...
04/10/2024 17:26:44

Cantor Fitzgerald analyst Charles Duncan reiterates Prothena Corp (NASDAQ:PRTA) with a Overweight.

Demystifying Prothena Corp: Insights From ...
03/13/2024 14:00:40

HC Wainwright & Co. Maintains Buy on Proth...
03/13/2024 13:25:49

HC Wainwright & Co. analyst Andrew Fein maintains Prothena Corp (NASDAQ:PRTA) with a Buy and maintains $90 price target.

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
02/29/2024 17:35:24

JMP Securities Maintains Market Outperform...
02/16/2024 19:58:22

JMP Securities analyst Jason Butler maintains Prothena Corp (NASDAQ:PRTA) with a Market Outperform and raises the price targ...

Decoding 6 Analyst Evaluations For Prothen...
02/16/2024 19:00:40

RBC Capital Maintains Sector Perform on Pr...
02/16/2024 17:44:45

RBC Capital analyst Brian Abrahams maintains Prothena Corp (NASDAQ:PRTA) with a Sector Perform and lowers the price target f...

Prothena Corp Q4 2023 GAAP EPS $(1.26) Mis...
02/15/2024 21:10:48

Prothena Corp (NASDAQ:PRTA) reported quarterly losses of $(1.26) per share which missed the analyst consensus estimate of $(1.2...

Prothena Corp: Q4 Earnings Insights
02/15/2024 21:10:10

Earnings Scheduled For February 15, 2024
02/15/2024 10:17:01

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on rev...